Madrigal Pharmaceuticals MDGL SEC Filings

NASDAQ MDGL
$541.93 -0.68 (-0.13%)
As of: Sep 4, 2026 · 2:26 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Madrigal Pharmaceuticals, Inc. (MDGL) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index